Stanford's Lab for Cell, Gene Medicine Opens in Palo Alto

Article Making cell- or virus-based therapies for use in humans requires a rigid set of quality-control standards outlined by the Food and Drug Administration. A new Stanford facility will allow promising new therapies to be tested in the clinic. Contributed Author:  Krista Conger and Christopher Vaughan, Stanford Medicine Topics:  STEM